Primo Water Corporation (Nasdaq:PRMW) reached up 32.68% in morning trading to $1.3401 with 550K shares traded. Primo Water Corporation was started in 2004 by Billy Prim, a successful entrepreneur and the founder of Blue Rhino, the market leader in propane grill cylinder exchange with over 29,000 retail locations in 49 states. Using the Blue Rhino model, Billy created Primo Water as a way to offer consumers both top quality in-home water dispensers and clean, purified water using an exchange process that does not create the waste produced by single-use bottles. Today the company produces the top-selling line of water dispensers in the United States, selling both traditional top-loading dispensers and innovative bottom-loading bottle dispensers at retail locations nationwide as well as online. Primo Water Corporation (Nasdaq:PRMW) yesterday announced financial results for the third quarter ended September 30, 2012.
Palatin Technologies, Inc. (NYSE MKT: PTN) reached up 30.33% in morning trading to $.8483 with 800K shares traded. Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. Palatin Technologies, Inc. (NYSE MKT: PTN) today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD).
Bacterin International Holdings, Inc. (NYSE MKT: BONE) reached up 8.06% in morning trading to $1.34 with 100K shares traded. Bacterin International Holdings, Inc. develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Bacterin International Holdings, Inc. (NYSE MKT: BONE) yesterday announced its financial results for the third quarter ended September 30, 2012: Revenue Increases 18%; Company Reports 71% Gross Margins and Attains Operational Profitability Conference Call at 4:30pm ET to Discuss Third Quarter 2012 Results
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
